Patents
Inventors: Bushra Ateeq, Scott A. Tomlins, Arul M. Chinnaiyan. U.S. Patent. University of Michigan, "SPINK1 Targeted Therapy". Application Number 13/023, 694, UM-31362/US-2/ORD. Issued 09 Feb, 2011.
Inventors: Bushra Ateeq, Vipul Bhatia, Anjali Yadav. Indian Patent, Indian Institute of Technology, Kanpur. "Medicament and Diagnosis for SPINK1 Positive Cancer". Filed: 15th May 2016. (Application Number: IN 201611016564). Patent Granted 392861.
Inventors: Nitesh Kumar, Vivek Verma, Laxmidhar Behera, Kaustubh Kulkarni, Bushra Ateeq, Nishat Manzar. Indian Provisional Patent, Indian Institute of Technology, Kanpur 'Iron Oxide Nanoparticles and Method of its Production'. Filed: 15th May 2017. (Application Number: 201711016919; granted). Patent Granted 356627.
Inventors: Bushra Ateeq, Anjali Yadav. Indian Provisional Patent, Indian Institute of Technology, Kanpur. "Chemosensitization of castrate-resistant prostate cancer to PARP inhibitors by MALAT1 ablation". Application Number: E-2/1119/2022/DEL (202111037231). Date of Filing: 17th August 2022.
Inventors: Bushra Ateeq, Sakshi Goel. US Patent, Indian Institute of Technology, Kanpur. "Therapeutic interventions for targeting DLX1 in prostate cancer". US patent Application Number: 18/147,030. Date of filing: December 28th 2022.
Inventors: Bushra Ateeq, Shivansh Nigam. Indian Provisional Patent, Indian Institute of Technology, Kanpur. "A Method For Diagnosis of DKC1 Positive Colorectal Cancer". Application Number: 202311017633. Date of Filing: 16th March 2023.